SEC Form 4 · accession 0001179110-18-009628
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Stoner
Director
Period of report
Jul 9, 2018
Accepted (ET)
Jul 11, 2018 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 9, 2018 | M | 6,000 | $13.16 | A | 32,253 | D | |
| Common Stock | Jul 9, 2018 | S | 4,462 | $23.00 | D | 27,791 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $13.16 | Jul 9, 2018 | M | 6,000 | D | Jun 12, 2015 | Jun 12, 2024 | Common Stock | 6,000 | 11,750 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.